CV Sciences, Inc. Logo
  • Home
  • About Us
    • Clinical Pipeline
    • Management Team
    • Board Of Directors
    • History
  • Pipeline
  • Consumer Products
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Investors

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Press Releases

CV Sciences, Inc. Announces Launch of ProCBD™ Product Line

Jan 5, 2021

CV Sciences, Inc. Receives Nutritional Outlook’s 2020 Best of the Industry Award

Dec 10, 2020

CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction

Dec 8, 2020

CV Sciences, Inc. Reports Third Quarter 2020 Financial Results

Nov 5, 2020

CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line

Nov 4, 2020

CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020

Oct 23, 2020

CV Sciences, Inc. Announces PlusCBD™ Brand Refresh and New Product Launches

Oct 6, 2020

CV Sciences, Inc. Announces Launch of CV™ Defense Daily Immune Support

Sep 10, 2020

CV Sciences, Inc. Launches New Website Reflecting Core Values and Mission of Improving Quality of Life Through Nature and Science

Sep 2, 2020

CV Sciences, Inc. to Participate in Alliance Global Partners Virtual Event

Aug 20, 2020
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...17
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

© CV Sciences, Inc. All Rights Reserved.

  • Home
  • About Us
    ▼
    • Clinical Pipeline
    • Management Team
    • Board Of Directors
    • History
  • Pipeline
  • Consumer Products
  • Investors
    ▼
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us